Lead Product(s): INVAC-1
Therapeutic Area: Oncology Product Name: Undisclosed
Highest Development Status: Phase I Product Type: Vaccine
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable January 08, 2020
This is the first in-human study of INVAC-1, an immune-therapeutic DNA vaccine for the treatment of cancer.